CytoMed Therapeutics (GDTC) vs Vistagen Therapeutics (VTGN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
CytoMed Therapeutics (GDTC) has outperformed Vistagen Therapeutics (VTGN) over the past year, losing 54.6% versus a loss of 93.8%. CytoMed Therapeutics is the larger company by market cap ($11.3 million vs $10.9 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | GDTC | VTGN |
|---|---|---|
| Share price | $0.9449 | $0.2462 |
| Market cap | $11.28M | $10.93M |
| 1-day change | -3.56% | -0.36% |
| YTD return | -26.59% | -62.56% |
| 1-year return | -54.63% | -93.76% |
| 5-year return | — | -99.66% |
| EPS (TTM) | $-0.23 | $-1.66 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.68 | $5.14 |
| 52-week low | $0.68 | $0.20 |
| Distance from 52-week high | -74.32% | -95.21% |
| Average volume | 78.41K | 12.38M |
| Shares outstanding | 11.93M | 44.38M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- GDTC has outperformed VTGN by 39.1 percentage points over the past year.
GDTC vs VTGN FAQ
Which is bigger, CytoMed Therapeutics or Vistagen Therapeutics?
CytoMed Therapeutics (GDTC) is larger, with a market capitalization of $11.28M compared with $10.93M for Vistagen Therapeutics (VTGN).
Which stock has performed better over the past year, GDTC or VTGN?
GDTC returned -54.63% over the past 12 months, compared with -93.76% for VTGN (price return, excluding dividends). Past performance does not predict future results.
Are CytoMed Therapeutics and Vistagen Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.